1 1128 175 EFFICACY OF VAMANA KARMA WITH IKSHVAKU KSHEERA YOGA IN THE MANAGEMENT OF TAMAKA SHVASA (BRONCHIAL ASTHMA). INTRODUCTION: BRONCHIAL ASTHMA IS A HIGHLY PREVALENT DISEASE, AND IN MOST OF THE ETIOPATHOGENESIS AND SYMPTOMATOLOGY, IT CAN BE CORRELATED WITH TAMAKA SHVASA. IKSHVAKU (LAGENARIA VULGARIS [MANILA] STANDLEY.) IS AN ANNUAL HERBACEOUS CLIMBING PLANT WITH A LONG HISTORY OF MEDICINAL USES FOR THE TREATMENT OF VARIOUS AILMENTS INCLUDING JAUNDICE, DIABETES, ULCER, PILES, COLITIS, ASTHMA, INSANITY, HYPERTENSION, CONGESTIVE CARDIAC FAILURE AND SKIN DISORDERS. ITS FRUIT PULP IS USED BOTH AS AN EMETIC AND AS A PURGATIVE. AIMS: TO STUDY THE EFFICACY OF VAMANA KARMA WITH IKSHVAKU (LAGENARIA VULGARIS [MANILA] STANDLEY) KSHEERA YOGA. MATERIALS AND METHODS: A TOTAL OF 15 PATIENTS FULFILLING THE DIAGNOSTIC CRITERIA FOR BRONCHIAL ASTHMA WERE SELECTED FROM OUTPATIENT AND INPATIENT DEPARTMENT OF PANCHAKARMA DEPARTMENT. THE SIGN AND SYMPTOMS, MAINLY BREATHLESSNESS, COUGH AND RHONCHI WERE GIVEN SCORES DEPENDING ON THEIR SEVERITY. THE PATIENTS WERE ALSO ASSESSED FOR LUNG FUNCTION TEST TO DETERMINE PULMONARY IMPAIRMENT. FOR VAMANA, THEY WERE GIVEN DEEPANA AND PACHANA WITH TRIKATU CHURNA FOR 3 DAYS AND THEN THEY WERE SUBJECTED TO SNEHAPANA WITH LUKEWARM COW'S GHEE. AFTER THE COMPLETION OF SNEHAPANA, THE PATIENT WERE GIVEN ABHYANGA, VASHPA SWEDANA AND DIET WITH PREDOMINANCE OF KAPHA (KAPHA BAHULA AHARA- DIET MIXED WITH MILK OR CURD), WHICH WAS THEN FOLLOWED BY VAMANA WITH IKSHVAKU KSHEERA YOGA AND SAMSARJANA KRAMA. FOLLOW-UP WAS DONE AT AN INTERVAL OF 15 DAYS FOR THREE TIMES AND T SCORES WERE NOTED BEFORE AND AFTER THE TREATMENT. THE SCORES WERE ANALYZED USING WILCOXON SIGNED-RANK TEST FOR SUBJECTIVE PARAMETERS AND STUDENT'S PAIRED T-TEST FOR OBJECTIVE PARAMETERS. RESULTS: THE TRIAL DRUG HAS SHOWN STATISTICALLY HIGHLY SIGNIFICANT REDUCTION IN BREATHLESSNESS, COUGH, RHONCHI, AND SIGNIFICANT CHANGES IN LUNG FUNCTION TESTS. CONCLUSION: THE TEST DRUG PROVED ITS EMETIC EFFECT ON THE PATIENTS OF BRONCHIAL ASTHMA AND THUS RELIEVED THE SYMPTOMS OF THE DISEASE IMMEDIATELY. IT HAS REDUCED FREQUENCY OF EPISODES OF BREATHLESSNESS AND SEVERITY OF SYMPTOMS. 2017 2 1665 27 NATUROPATHY AND YOGA FOR IMPROVING QUALITY OF LIFE IN PEMPHIGUS VULGARIS AND MANAGING CO-MORBID TYPE 2 DIABETES: A CASE REPORT. A 57 YEARS OLD MALE PATIENT WAS ADMITTED TO AN INPATIENT NATUROPATHY AND YOGA (N&Y) HOSPITAL, DIAGNOSED WITH PEMPHIGUS VULGARIS (PV) FOR ONE YEAR AND CO-MORBID TYPE 2 DIABETES (T2DM) FOR 10 YEARS, ASSOCIATED WITH POOR QUALITY OF LIFE (QOL). HE WAS ADMINISTERED N&Y THERAPIES FOR 10 DAYS, ALONG WITH CONVENTIONAL MEDICINES. THERE WAS IMPROVED QOL AND REDUCED DOSAGE OF INSULIN, ALONG WITH REDUCTION IN BODY WEIGHT. THESE CHANGES WERE SUSTAINED AND IMPROVED FURTHER DURING THE 60-DAY FOLLOW-UP PERIOD. ALTHOUGH THERE WAS NO IMPROVEMENT IN THE SKIN LESIONS, THE IMPROVEMENT IN QOL INDICATE A POSSIBLE ROLE OF N&Y IN MANAGEMENT OF PV AND T2DM. THIS CASE REPORT ALSO WARRANTS FURTHER STUDIES FOR N&Y IN THE MANAGEMENT OF DERMATOLOGICAL CONDITIONS AS WELL AS METABOLIC SYNDROME. 2020 3 483 54 CLINICAL EFFICACY OF VAMANA KARMA WITH IKSHWAAKU BEEJA YOGA FOLLOWED BY SHATAPUSHPADI GHANAVATI IN THE MANAGEMENT OF ARTAVA KSHAYA W. S. R TO POLYCYSTIC OVARIAN SYNDROME. BACKGROUND: DUE TO SEDENTARY LIFESTYLE AND STRESS, THE INCIDENCE OF METABOLIC DISORDERS ARE INCREASING DAY BY DAY. AMONG THESE POLYCYSTIC OVARIAN SYNDROME (PCOS) IS AN INTRICATE DISORDER AFFECTING 4%-8% WOMEN IN THEIR REPRODUCTIVE AGE AND RELATED TO OVARIAN DYSFUNCTION CHARACTERIZED BY OBESITY, OLIGOMENORRHEA, ANOVULATION AND HYPERANDROGENISM. IN MODERN SYSTEM OF MEDICINE, THE AVAILABLE ALLOPATHIC REGIMEN HAS ITS OWN LIMITATIONS, SO IT IS NEED OF TIME TO FIND A SAFE AND EFFECTIVE ALTERNATIVE THERAPY FOR SUCH TYPE OF CONDITION. THE MOST COMMON SYMPTOM IN 85%-90% OF PCOS PATIENTS IS OLIGOMENORRHEA WHICH CAN BE CORRELATED TO ARTAVA KSHAYA (LOSS OF MENSTRUAL FLUID) IN AYURVEDA. HENCE, IN THE PRESENT CLINICAL STUDY, VAMANA KARMA (THERAPEUTIC VOMITING) WITH IKSHWAAKU SEED FORMULATION FOLLOWED BY SHATAPUSHPADI GHANAVATI WAS PLANNED. AIMS: TO EVALUATE THE EFFICACY OF VAMANA KARMA (THERAPEUTIC VOMITING) FOLLOWED BY SHATAPUSHPADI GHANAVATI IN THE MANAGEMENT OF AARTAVA KSHAYA (LOSS OF MENSTRUAL FLUID) W. S. R TO PCOS. MATERIALS AND METHODS: A TOTAL OF 15 PATIENTS OF PCOS WERE CLINICALLY DIAGNOSED AND TREATED BY VAMANA KARMA (THERAPEUTIC VOMITING) PROCEDURE WITH IKSHWAAKU SEED FORMULATION. AFTER COMPLETION OF VAMANA KARMA (THERAPEUTIC VOMITING) AND SAMSARJANA KRAMA, (POST THERAPY DIETARY REGIMEN FOR REVIVAL) SHATAPUSHPADI GHANAVATI 2 VATI (EACH 500 MG) TWICE IN A DAY WITH LUKEWARM WATER WAS GIVEN FOR 45 DAYS. AFTER COMPLETION OF 2-MONTH TRIAL, ASSESSMENT OF THERAPY WAS ESTIMATED BY SUBJECTIVE AND OBJECTIVE PARAMETERS. RESULTS: STATISTICALLY EXTREMELY SIGNIFICANT (P < 0.0001) RESULTS WERE FOUND IN MENSTRUAL IRREGULARITIES, OBESITY, AND BODY MASS INDEX. THE SIGNIFICANT RESULT IN REDUCTION OF NONDOMINANT FOLLICLES (P = 0.01 AND 0.03 FOR RIGHT AND LEFT OVARY, RESPECTIVELY), LOWERING THE FASTING BLOOD SUGAR LEVEL (P = 0.02) AND HIRSUTISM (P = 0.03) WAS FOUND. CONCLUSION: VAMANA KARMA (THERAPEUTIC VOMITING) FOLLOWED BY SHATAPUSHPADI GHANAVATI IS VERY EFFECTIVE IN THE MANAGEMENT OF OBESE PCOS PATIENTS AND INCREASING CHANCES OF CONCEPTION. 2017 4 1476 29 INTEGRATED YOGA AND NATUROPATHY MODULE IN MANAGEMENT OF METABOLIC SYNDROME: A CASE REPORT. A 50-YEAR-OLD MALE PARTICIPANT WITH SEDENTARY LIFESTYLE, DIAGNOSED WITH METABOLIC SYNDROME (METS) [OBESITY, TYPE-2 DIABETES MELLITUS, HYPERTENSION] AND HYPOTHYROIDISM SINCE 2013, WAS ADMINISTERED INTEGRATED YOGA AND NATUROPATHY (IYN) FOR 6 WEEKS AS A TAILOR MADE INDIVIDUALIZED PROTOCOL AT THE RESIDENTIAL INTEGRATIVE MEDICAL FACILITY IN BANGALORE BETWEEN OCTOBER AND NOVEMBER 2015. THE RESULTS SHOWED REDUCTION IN WEIGHT (97.9 KG TO 74.6 KG), BODY MASS INDEX (BMI) (35.1 KG/M(2) TO 27.86 KG/M(2)), TOTAL CHOLESTEROL (192 MG% TO 145 MG%), TRIGLYCERIDES (153 MG% TO 90 MG%), LOW DENSITY LIPOPROTEIN (LDL) (124 MG% TO 81 MG%), HIGH DENSITY LIPOPROTEIN (HDL) (40 MG% TO 46 MG%), FASTING BLOOD GLUCOSE (110 MG/DL TO 75 MG/DL), POSTPRANDIAL GLUCOSE (267 MG/DL TO 100 MG/DL), GLYCATED HEMOGLOBIN (HBA1C) (7.8%-7.1%), THYROID STIMULATING HORMONE (TSH) (6.90 MUIU/ML TO 3.052 MUIU/ML). FOLLOWING THE INTERVENTION, THE ANTI-HYPERTENSIVE, ORAL HYPOGLYCEMIC, THYROID RAISING AND ANALGESIC MEDICINES WERE NOT REQUIRED TO BE CONTINUED. HIS KNEE PAIN MINIMIZED ON DISCHARGE AS OBSERVED ON A VISUAL ANALOG SCALE. HE HAD AN IMPROVED FEELING OF WELLNESS AND OVERALL FUNCTIONAL HEALTH. ALL HIS PARAMETERS WERE WITHIN NORMAL RANGE AT THE 12-WEEKS FOLLOW-UP, AS HE HAD INCORPORATED THE LIFESTYLE PROGRAM INTO HIS DAILY ROUTINE. THIS CASE REPORT SUGGESTS THAT LIFESTYLE CHANGE BY INTEGRATION OF SPECIFIC NON-DRUG YOGA AND NATUROPATHIC INTERVENTION IS USEFUL IN THE MANAGEMENT OF METS. 2017 5 2283 47 THE USE OF INTEGRATIVE THERAPY BASED ON YOGA AND AYURVEDA IN THE TREATMENT OF A HIGH-RISK CASE OF COVID-19/SARS-COV-2 WITH MULTIPLE COMORBIDITIES: A CASE REPORT. BACKGROUND: WE REPORT A HIGH-RISK CASE OF A CORONAVIRUS DISEASE 19 (COVID-19)-POSITIVE PATIENT WITH COMORBIDITIES INCLUDING DIABETES MELLITUS (DM), HYPERTENSION (HTN), HYPOTHYROIDISM AND CHRONIC KIDNEY DISEASE (CKD), TREATED SUCCESSFULLY USING AN INTEGRATIVE THERAPY PLAN BASED ON AYURVEDA AND YOGA, ALONG WITH GOVERNMENT-MANDATED COMPULSORY MODERN WESTERN MEDICINE (MWM) TREATMENT. RECENTLY, SOME EVIDENCE HAS BEEN EMERGING ON THE USE OF AYURVEDA FOR TREATMENT OF COVID-19. THE CLASSICAL TEXTS OF AYURVEDIC MEDICINE SUCH AS CHARAKA SAMHITA AND SUSHRUTA SAMHITA CONTAIN DESCRIPTIONS OF PANDEMICS OF SIMILAR PROPORTIONS AND DESCRIBE THEM AS JANAPADODDHVANSA, MEANING THE DESTRUCTION OF COMMUNITIES, ALONG WITH THEIR CAUSES AND TREATMENT. CASE PRESENTATION: THE CASE REPORTED HEREIN IS A 55-YEAR-OLD MAN FROM DELHI, INDIA, WITH CONFIRMED (TESTED) COVID-19, WHO FIRST TOOK MWM FOR 7 DAYS BEFORE SEEKING INTEGRATIVE THERAPY. THE PATIENT HAS COMORBIDITIES INCLUDING DM, HTN, HYPOTHYROIDISM AND CKD AND HAD DEVELOPED SYMPTOMS INCLUDING FEVER (WHICH WAS RESOLVED BY THE TIME INTEGRATIVE THERAPY WAS STARTED), SORE THROAT, DRY COUGH, BODY ACHES, WEAKNESS, BAD TASTE AND SMELL, AND HEAVINESS IN THE ABDOMEN. BASED ON THE PATIENT'S SYMPTOMS AND COMORBIDITIES, A TREATMENT PLAN INCLUDING AYURVEDIC MEDICINES, YOGA PROTOCOL, DIETARY RECOMMENDATIONS AND LIFESTYLE MODIFICATIONS WAS PRESCRIBED BY A REGISTERED AYURVEDA DOCTOR AND A YOGA CONSULTANT. THE PATIENT STARTED EXPERIENCING IMPROVEMENT IN ALL THE SYMPTOMS WITHIN 2 DAYS AFTER STARTING THE TREATMENT; HE REPORTED APPROXIMATELY [FORMULA: SEE TEXT] RELIEF FROM THE SYMPTOMS AFTER 5 DAYS, AND ALMOST COMPLETE RELIEF WITHIN 9 DAYS. ALSO, THE BLOOD SUGAR LEVELS (BOTH FASTING BLOOD SUGAR [FBS] AND POSTPRANDIAL BLOOD SUGAR [PPBS]) EXHIBITED SIGNIFICANT IMPROVEMENT AFTER 5 DAYS, AND DECREASED TO WITHIN THE NORMAL RANGE WITHIN 12 DAYS. BESIDES RELIEF IN SYMPTOMS, THE PATIENT'S REAL-TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION (RT-PCR) TEST DONE ON THE 19TH DAY RETURNED NEGATIVE RESULTS. CONCLUSIONS: INTEGRATIVE THERAPY WAS FOUND TO BE EFFECTIVE IN MITIGATING THE SYMPTOMS OF COVID-19 IN THIS PATIENT WITH MULTIPLE COMORBIDITIES. MOREOVER, A SIGNIFICANT IMPROVEMENT IN BLOOD SUGAR LEVELS (NOT UNDER CONTROL WITH MODERN MEDICINE) WAS ALSO ACHIEVED. INTEGRATIVE THERAPY BASED ON THE CLASSICAL TEXTS OF AYURVEDA AND YOGA MAY OFFER A PROMISING AND SCALABLE TREATMENT OPTION FOR COVID-19 PATIENTS. A CASE SERIES OR A SUITABLY DESIGNED RANDOMIZED CONTROLLED TRIAL IS NEEDED TO ASSESS ITS EFFICACY. 2021 6 718 22 EFFECT OF INTEGRATIVE NATUROPATHY AND YOGA IN A PATIENT WITH RHEUMATOID ARTHRITIS ASSOCIATED WITH TYPE 2 DIABETES AND HYPERTENSION. A 54-YEAR OLD MARRIED WOMAN WAS DIAGNOSED WITH RHEUMATOID ARTHRITIS IN 2002, ESSENTIAL HYPERTENSION IN 2008, TYPE-2 DIABETES IN 2011 AND GANGRENE OVER 2(ND) TOE OF RIGHT FOOT. SHE UNDERWENT CONVENTIONAL MANAGEMENT IN PRIVATE HOSPITALS. HER SYMPTOMS, BEGAN WITH MODERATE TO SEVERE PAIN ASSOCIATED WITH SWELLING, STIFFNESS (MORE IN THE MORNING) IN MULTIPLE JOINTS ESPECIALLY OVER SMALL JOINTS. IN JULY-2014 SHE VISITED OUR COLLEGE HOSPITAL WITH THE COMPLAINTS OF PAIN, MILD SWELLING AND STIFFNESS OVER MULTIPLE JOINTS ASSOCIATED WITH POOR QUALITY OF SLEEP (QOS) AND QUALITY OF LIFE (QOL). SUBJECT RECEIVED INTEGRATIVE NATUROPATHY AND YOGA THERAPIES (INYT) WITH CONVENTIONAL MEDICINE DAILY FOR 10-DAYS. AFTER 10-DAYS, IMPROVEMENTS IN PAIN, BLOOD SUGAR, DEPRESSION, ANXIETY, STRESS, QOS, QOL, BLOOD ANALYSIS WITH NORMAL BLOOD PRESSURE (BP) WAS OBSERVED. THIS SUGGESTS THAT INYT COULD BE CONSIDERED AS AN ADJUVANT TO CONVENTIONAL MEDICINE IN RA ASSOCIATED WITH TYPE-2 DIABETES AND ESSENTIAL HYPERTENSION. 2017 7 2885 51 YOGA: AS AN ADJUNCT THERAPY TO TRIM DOWN THE AYURVEDIC DRUG REQUIREMENT IN NON INSULIN-DEPENDENT DIABETES MELLITUS. INTRODUCTION: IN SPITE OF A LARGE NUMBER OF DRUGS SHOWING ANTI-HYPERGLYCEMIC ACTIVITIES, NONE OF THEM HAVE BEEN SUCCESSFUL IN COMPLETE MANAGEMENT OF DIABETES MELLITUS (DM). YOGA AND AYURVEDA ARE THE TWO SCHOOLS OF THOUGHT IN INDIA, WHICH HAVE A HISTORY OF CURING DISEASES SINCE THOUSANDS OF YEARS. YOGIC TECHNIQUES AND AYURVEDIC HERBS HAVE PROVEN THEIR ANTI-DIABETIC POTENTIAL WITHOUT INDUCING UNTOWARD EFFECTS. THE PRESENT STUDY COMBINES AYURVEDIC MEDICATION WITH YOGA TECHNIQUES AS A NEW APPROACH TOWARD HEALING DM. AIMS AND OBJECTIVES: TO ASSESS THE EFFECT OF YOGA THERAPY IN THE MANAGEMENT OF NON INSULIN-DEPENDENT DM (NIDDM) AND TO DECREASE THE ORAL DRUG DOSE REQUIREMENT OF GUDUCI GHANA TABLET. MATERIALS AND METHODS: THIRTY KNOWN NIDDM PATIENTS OF BOTH GENDERS, WHO WERE ON GUDUCI GHANA (SOLIDIFIED AQUEOUS EXTRACT OF TINOSPORA CORDIFOLIA (WILLD.) MIERS.) TABLETS FROM PAST 2 MONTHS AS AYURVEDIC REMEDY FOR DM WERE SELECTED. ALONG WITH GUDUCI GHANA ADMINISTRATION, THE SUBJECTS WERE INSTRUCTED TO FOLLOW YOGIC PROCEDURES INCLUDING ASANAS, PRANAYAMA, AND SUDDHI KRIYAS. THE STUDY WAS CONDUCTED FOR 8 WEEKS, WHEREIN FASTING BLOOD SUGAR (FBS) AND POSTPRANDIAL BLOOD SUGAR (PPBS) LEVELS ALONG WITH RELIEF IN SIGN AND SYMPTOMS WERE ASSESSED AT EVERY 2 WEEKS INTERVALS, AND ACCORDING TO RELIEF IN SIGN AND SYMPTOMS, TAPERING OF DRUG DOSAGE WAS CARRIED OUT. THE OBTAINED DATA WERE ANALYZED STATISTICALLY BY APPLYING PAIRED T-TEST. RESULTS AND CONCLUSION: THE RESULTS OBTAINED WERE PROMISING AS THE RELIEF IN DIABETIC SYMPTOMATOLOGY WAS HIGHLY SIGNIFICANT IN TERMS OF P VALUE. 80.83% REDUCTION IN DOSE OF GUDUCI GHANA TABLETS AND 7.85% AND 8.78% FALL IN FBS AND PPBS LEVELS, RESPECTIVELY, AFTER THE COMPLETE COURSE OF TREATMENT. THE OBTAINED P VALUE SHOWED HIGHLY SIGNIFICANT RESULTS. 2014 8 776 32 EFFECT OF YOGA AND NATUROPATHY-BASED LIFESTYLE MODIFICATION ON LEFT VENTRICULAR EJECTION FRACTION IN A PATIENT WITH SEVERE TRIPLE VESSEL DISEASE: A CASE REPORT. A 75-YEAR-OLD, MARRIED MAN WAS DIAGNOSED WITH CORONARY ARTERY DISEASE (CAD) [SEVERE TRIPLE VESSEL DISEASE (TVD)] IN THE 2(ND) WEEK, JUNE-2018. THE PHYSICIAN ADVISED HIM TO UNDERGO CONVENTIONAL MEDICATION AND CORONARY ARTERY BYPASS GRAFT. SINCE THE PATIENT REFUSED TO UNDERGO SURGERY HE WAS ADMITTED IN OUR HOSPITAL AND UNDERWENT YOGA AND NATUROPATHY-BASED LIFESTYLE MODIFICATION (YNLM) ALONG WITH CONVENTIONAL MEDICINES FOR 16 WEEKS [12 WEEKS OF INTENSIVE CARE AT INPATIENT DEPARTMENT AND 4 WEEKS AT OUTPATIENT DEPARTMENT (OPD)]. AFTER 16 WEEKS, THE PATIENT VISITED OUR OPD ONCE/TWICE A MONTH FOR 6 MONTHS. AN INCREASE IN LEFT VENTRICULAR EJECTION FRACTION FROM 35 TO 48%; AND A REDUCTION IN WEIGHT FROM 77.5 TO 71-KG, AND BMI FROM 26.60 TO 24-KG/M(2) WERE OBSERVED AFTER 6 MONTHS OF FOLLOW-UP COMPARED WITH BASELINE. THUS, YNLM MIGHT BE CONSIDERED AS AN ADJUVANT IN REDUCING RISK FACTOR AND IN IMPROVING LEFT VENTRICULAR SYSTOLIC DYSFUNCTION IN PATIENTS WITH CAD (SEVERE-TVD). HOWEVER, FURTHER STUDIES ARE REQUIRED TO ESTABLISH THE EFFICACY OF YNLM FOR CAD. 2020 9 2570 21 YOGA FOR DERMATOLOGIC CONDITIONS. AS BOTH A DERMATOLOGY RESIDENT AND YOGA INSTRUCTOR, I FIND THE POTENTIAL CORRELATION BETWEEN THE 2 DISCIPLINES TO BE INTERESTING AND A GROWING TOPIC OF ATTENTION IN THE MEDIA TODAY. WITH THE RISING TREND OF PRACTICING YOGA, WHICH ENCOMPASSES PHYSICAL POSTURES, BREATHING EXERCISES, AND MEDITATION OR MINDFULNESS, IT IS INEVITABLE THAT PATIENTS WILL INQUIRE ABOUT THE BENEFITS OF YOGA IN MANAGING DERMATOLOGIC PROBLEMS. IN THIS COLUMN, I WILL DISCUSS THE DERMATOLOGIC MANIFESTATIONS OF STRESS AS WELL AS THE KNOWN HEALTH BENEFITS OF YOGA AS DESCRIBED IN THE LITERATURE SO THAT RESIDENTS MAY OFFER AN OBJECTIVE OPINION ABOUT YOGA IN RESPONSE TO PATIENT INQUIRIES. 2015 10 689 41 EFFECT OF AYURVEDA INTERVENTION, LIFESTYLE MODIFICATION AND YOGA IN PREDIABETIC AND TYPE 2 DIABETES UNDER THE NATIONAL PROGRAMME FOR PREVENTION AND CONTROL OF CANCER, DIABETES, CARDIOVASCULAR DISEASES AND STROKE (NPCDCS)-AYUSH INTEGRATION PROJECT. BACKGROUND: TYPE 2 DIABETES IS A LIFESTYLE-RELATED DISORDER THAT AFFECTS AROUND 422 MILLION INDIVIDUALS IN INDIA. INTEGRATION OF AYUSH (AYURVEDA) WITH THE NATIONAL PROGRAMME FOR PREVENTION AND CONTROL OF CANCER, DIABETES, CARDIOVASCULAR DISEASES AND STROKE (NPCDCS) WAS CONCEIVED ON PILOT BASIS AT GAYA, BIHAR, TO PROVIDE INTEGRATIVE TREATMENT FOR NON-COMMUNICABLE DISEASE PATIENTS AND TO MANAGE THE BURDEN OF NON-COMMUNICABLE DISEASES IN INDIA. OBJECTIVES: THE OBJECTIVE OF THIS STUDY WAS TO ANALYZE THE EFFECT OF AYURVEDA INTERVENTION, LIFESTYLE MODIFICATION AND YOGA IN THE MANAGEMENT OF TYPE 2 DIABETES UNDER NPCDCS-AYUSH INTEGRATION PROJECT. MATERIALS AND METHODS: A MULTI-CENTRIC, OPEN-LABELED, PROSPECTIVE, COMPARATIVE CLINICAL STUDY WAS CONDUCTED AT 17 COMMUNITY HEALTH CENTERS AND 1 DISTRICT HOSPITAL. POPULATION OVER 30 YEARS OF AGE WAS SCREENED AND PREDIABETIC OR TYPE 2 DIABETIC INDIVIDUALS WERE ENROLLED IN TWO COHORTS, I.E., PRE-DIABETIC (COHORT A) AND TYPE 2 DIABETIC (COHORT B). EACH COHORT WAS FURTHER DIVIDED INTO TWO GROUPS: GROUP A1 WAS ADVISED FOR LIFESTYLE MODIFICATION AND YOGA AND GROUP A2 WAS GIVEN AYURVEDA MEDICATION IN ADDITION TO LIFESTYLE MODIFICATION AND YOGA. SIMILARLY, GROUP B1 WAS ADVISED FOR LIFESTYLE MODIFICATION AND YOGA ALONG WITH ALLOPATHIC MEDICATION AND GROUP B2 WAS GIVEN AYURVEDA MEDICATION, I.E., MAMAJJAKA, AMALAKI AND GUDUCHI POWDER IN ADDITION TO LIFESTYLE MODIFICATION AND YOGA ALONG WITH ALLOPATHIC MEDICATION. TREATMENT WAS GIVEN FOR 6 MONTHS. DATA WERE ANALYZED THROUGH PAIRED T-TEST. RESULTS: A SIGNIFICANT REDUCTION WAS OBSERVED IN FASTING BLOOD SUGAR LEVEL IN GROUPS A2 AND B2 (P = 0.001) AND ALSO IN THE POSTPRANDIAL BLOOD SUGAR LEVEL IN GROUPS A2 AND B2 (P = 0.001). FURTHER, IMPROVEMENT IN SUBJECTIVE SYMPTOMS SUCH AS POLYURIA, POLYDIPSIA, POLYPHAGIA, BLURRED VISION AND WEAKNESS WAS FOUND IN ALL THE GROUPS, WHILE NON-HEALING ULCER DOES NOT SHOW ANY IMPROVEMENT. CONCLUSION: THE STUDY REVEALS THAT AYURVEDA INTERVENTION, I.E., MAMAJJAKA CHURNA (1 G), AMALAKI CHURNA (3 G) AND GUDUCHI CHURNA (3 G) TWO TIMES A DAY EFFECTIVELY CONTROLS BLOOD SUGAR LEVEL IN PRE-DIABETIC AND TYPE 2 DIABETIC PATIENTS AND IMPROVES THE DISEASE MANAGEMENT WITH LIFESTYLE MODIFICATION AND YOGASANA AS WELL AS WITH ALLOPATHIC TREATMENT. 2019 11 839 29 EFFECT OF YOGA ON PLASMA GLUCOSE, LIPID PROFILE, BLOOD PRESSURE AND INSULIN REQUIREMENT IN A PATIENT WITH TYPE 1 DIABETES MELLITUS. OBJECTIVES: THE OBJECTIVE OF THE STUDY IS TO EVALUATE THE SHORT-TERM EFFECT OF YOGA ON PLASMA GLUCOSE, LIPID PROFILE, BLOOD PRESSURE AND INSULIN REQUIREMENT IN A PATIENT WITH TYPE 1 DIABETES MELLITUS (T1DM). CASE PRESENTATION: A 28-YEARS OLD FEMALE WAS DIAGNOSED WITH T1DM AT THE AGE OF SEVEN. SHE WAS UNDER HUMAN MIXTARD INSULIN 30-70, THRICE/DAY FOR 15-15-15 UNITS. SHE HAD A HISTORY OF POOR GLYCEMIC CONTROL, DIABETIC KETOACIDOSIS AND HYPOGLYCEMIC SHOCK. AT THE AGE OF 27, SHE GOT ADMITTED WITH COMPLAINTS OF GENERAL WEAKNESS, JOINTS STIFFNESS AND WEIGHT LOSS IN OUR HOLISTIC HEALTH CENTRE AND UNDERWENT TWO WEEKS OF YOGA. RESULTS SHOWED A BETTER REDUCTION IN THE PLASMA GLUCOSE LEVELS, LIPID PROFILE, BLOOD PRESSURE AND INSULIN DOSE AND AN INCREASE IN HEMOGLOBIN LEVELS WITH NO EPISODES OF HYPOGLYCEMIA AFTER YOGA. CONCLUSIONS: YOGA MIGHT BE CONSIDERED AS A SAFER AND EFFECTIVE ADJUVANT IN THE MANAGEMENT OF T1DM. 2021 12 1485 34 INTEGRATIVE APPROACH COMBINING AYURVEDA, COUNSELLING, YOGA AND MEDITATION WITH CONVENTIONAL MANAGEMENT OF ANKYLOSING SPONDYLITIS - A CASE REPORT. LIFELONG MEDICATIONS ARE REQUIRED FOR SYMPTOMATIC RELIEF IN ANKYLOSING SPONDYLITIS (AS). WE REPORT THE POTENTIAL OF AN INTEGRATIVE APPROACH IN REDUCING DEPENDENCE ON STEROIDS AND PAIN MEDICATIONS IN CHRONIC AS. A 59-YEAR-OLD HLA-B27 POSITIVE MALE PATIENT SUFFERING FROM AS FOR 40 YEARS SOUGHT AYURVEDIC TREATMENT FOR RELAPSE OF PAIN, STIFFNESS, FATIGUE, INTERMITTENT CONSTIPATION AND DISTURBED SLEEP. AYURVEDIC DIAGNOSIS WAS AMAVATA (A CLINICAL CONDITION CHARACTERISED BY JOINT INFLAMMATION) THE PATIENT WAS MANAGED AS OUTPATIENT FOR ELEVEN DAYS AND HOSPITALISED FOR THIRTY THREE DAYS. INTERNAL MEDICINES AND EXTERNAL THERAPIES WITH DIET MODIFICATION, LIFESTYLE ADJUSTMENTS, COUNSELLING, YOGA AND IAM TECHNIQUE (INTEGRATED AMRITA MEDITATION TECHNIQUE ) WERE ADMINISTERED DURING THE HOSPITAL STAY. AT YEARLY FOLLOW UP, C-REACTIVE PROTEIN WAS REDUCED TO 15.7 MG/L FROM THE BASELINE VALUE OF 37.5 MG/L, AND ESR FROM 103 MM/H TO 8 MM/H INDICATING REDUCTION IN INFLAMMATION. THE DOSE OF NSAID AND DMARD (DISEASE MODIFYING ANTIRHEUMATIC DRUG) COULD BE REDUCED FROM ONCE IN TWENTY-FOUR HOURS TO ONCE IN EIGHTY-FOUR HOURS AND STEROIDS FROM TWICE DAILY TO ONCE IN A WEEK. THERE WAS SIGNIFICANT REDUCTION IN PAIN AND STIFFNESS. INTEGRATION OF AYURVEDA AND YOGA WITH CONVENTIONAL TREATMENT CAN REDUCE DRUG DEPENDENCE AND IMPROVE QUALITY OF LIFE IN AS. 2022 13 704 29 EFFECT OF INTEGRATED APPROACH OF YOGA AND NATUROPATHY ON POLYCYSTIC OVARIAN SYNDROME: A CASE STUDY. OWING TO STRESS, SEDENTARY LIFESTYLE AND CHANGES IN DIET PATTERN, THERE IS AN INCREASE IN THE SURGE OF LIFESTYLE AND METABOLIC DISORDERS. POLYCYSTIC OVARIAN SYNDROME (PCOS) AFFECTS 8-13% OF REPRODUCTIVE-AGED WOMEN. PCOS IS CHARACTERISED BY MENSTRUAL IRREGULARITY, HYPERANDROGENISM AND POLYCYSTIC OVARIAN MORPHOLOGY (PCOM). THE EFFICACY OF YOGA AS A THERAPY TO TACKLE THE DIRECT AND INDIRECT CAUSE OF AILMENT IN THE MANAGEMENT OF PCOS IS TO BE DOCUMENTED. THIS IS THE CASE STUDY OF A FEMALE PATIENT AGE 25 YEARS, A DIAGNOSED CASE OF PCOS WAS REGISTERED AT THE AYURVEDA, YOGA, UNANI,SIDDHA,HOMEOPATHY (AYUSH), YOGA OPD, WITH COMPLAINTS OF IRREGULAR MENSTRUATION, TREATED SUCCESSFULLY BY YOGA AND NATUROPATHY (Y AND N), I.E., YOGA, DIET AND LIFESTYLE MODIFICATION. THIS IS EVIDENT FROM THE REDUCTION IN WEIGHT, REGULARISATION OF THE MENSTRUAL CYCLE ALONG WITH MORPHOLOGICAL CHANGES IN THE OVARY AFTER A FOLLOW-UP OF 6 MONTHS. 2022 14 775 30 EFFECT OF YOGA AND NATUROPATHY ON LIVER, RENAL AND CARDIORESPIRATORY FUNCTIONS OF A PATIENT WITH HEPATIC CIRRHOSIS WITH PORTAL HYPERTENSION AND ASCITES: A CASE REPORT. A 39-YEAR-OLD, MARRIED MAN WAS DIAGNOSED WITH HEPATIC CIRRHOSIS WITH PORTAL HYPERTENSION AND ASCITES IN FEBRUARY 2016. HIS SYMPTOMS AS DESCRIBED BY HIM BEGAN WITH GENERALIZED BODY WEAKNESS, BREATHLESSNESS AND SUDDEN WEIGHT GAIN OF 16KG WITHIN 3 WEEKS. HISTORY OF REGULAR INTAKE OF ALCOHOL SINCE 7 YEARS AND TREMENDOUS FAMILY STRESS WERE PRESENT. PATIENT UNDERWENT CONVENTIONAL MEDICATION FOR 6 MONTHS AND AYURVEDIC MEDICATIONS FOR 4 MONTHS. IN JANUARY 2017, HE VISITED OUR HOSPITAL WITH THE SAME COMPLAINTS AND UNDERWENT INTEGRATED NATUROPATHY AND YOGA THERAPIES (INYTS) FOR 4 WEEKS ALONG WITH AYURVEDA AND CONVENTIONAL MEDICATIONS. THE RESULTS OF THIS STUDY SHOWED A BETTER REDUCTION IN BODY WEIGHT, BODY MASS INDEX, ABDOMINAL GIRTH, SYSTOLIC BLOOD PRESSURE AND DIASTOLIC BLOOD PRESSURE ALONG WITH IMPROVEMENT IN BREATH HOLDING TIME, HEMOGLOBIN LEVEL, LIVER FUNCTION TEST AND RENAL FUNCTION TEST. IT SUGGESTS THAT 4 WEEKS OF INYT WITH AYURVEDA AND CONVENTIONAL MEDICATIONS WAS EFFECTIVE IN PATIENTS WITH HEPATIC CIRRHOSIS WITH PORTAL HYPERTENSION AND ASCITES. FURTHER STUDIES ARE REQUIRED TO WARRANT THESE RESULTS. 2018 15 1374 38 IMPACT OF AN INTEGRATED YOGA THERAPY PROTOCOL ON INSULIN RESISTANCE AND GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. OBJECTIVE: DIABETES MELLITUS (DM), CHARACTERIZED BY CHRONIC HYPERGLYCEMIA, IS ATTRIBUTED TO RELATIVE INSULIN DEFICIENCY OR RESISTANCE, OR BOTH. STUDIES HAVE SHOWN THAT YOGA CAN MODULATE PARAMETERS OF INSULIN RESISTANCE. THE PRESENT STUDY EXPLORED THE POSSIBLE BENEFICIAL EFFECTS OF INTEGRATED YOGA THERAPY WITH REFERENCE TO GLYCEMIC CONTROL AND INSULIN RESISTANCE (IR) IN INDIVIDUALS WITH DIABETES MAINTAINED ON STANDARD ORAL MEDICAL CARE WITH YOGA THERAPY, COMPARED TO THOSE ON STANDARD ORAL MEDICAL CARE ALONE. METHODS: IN THIS STUDY, THE SUBJECTS ON YOGA INTERVENTION COMPRISED 35 TYPE 2 DIABETICS, AND AN EQUAL NUMBER OF VOLUNTEERS CONSTITUTED THE CONTROL GROUP. SUBJECTS RANGED IN AGE FROM 30 TO 70 YEARS, WITH HEMOGLOBIN A1C (HBA1C) TEST MORE THAN 7%, AND WERE MAINTAINED ON DIABETIC DIET AND ORAL HYPOGLYCEMIC AGENTS. BLOOD SAMPLES WERE DRAWN PRIOR TO AND AFTER 120 DAYS OF INTEGRATED YOGA THERAPY INTERVENTION. FASTING BLOOD GLUCOSE (FBG), POST-PRANDIAL BLOOD GLUCOSE (PPBG), HBA1C, INSULIN, AND LIPID PROFILE WERE ASSESSED IN BOTH THE INTERVENTION AND CONTROL GROUPS. RESULTS: THE INTERVENTION GROUP REVEALED SIGNIFICANT IMPROVEMENTS IN BODY MASS INDEX (BMI) (0.7 KG/M(2) MEDIAN DECREASE; P=0.001), FBG (20 MG/DL MEDIAN DECREASE; P<0.001), PPBG (33 MG/DL MEDIAN DECREASE; P<0.001), HBA1C (0.4% MEDIAN DECREASE; P<0.001), HOMEOSTATIC MODEL ASSESSMENT FOR INSULIN RESISTANCE (HOMA-IR) (1.2 MEDIAN DECREASE; P<0.001), CHOLESTEROL (13 MG/DL MEDIAN DECREASE, P=0.006), TRIACYLGLYCEROL (22 MG/DL MEDIAN DECREASE; P=0.027), LOW-DENSITY LIPOPROTEIN (6 MG/DL MEDIAN DECREASE; P=0.004), AND VERY-LOW-DENSITY LIPOPROTEIN LEVELS (4 MG/DL MEDIAN DECREASE; P=0.032). INCREASES IN HIGH-DENSITY LIPOPROTEIN AFTER 120 DAYS WERE NOT SIGNIFICANT (6 MG/DL MEDIAN INCREASE; P=0.15). HOWEVER, WHEN COMPARED TO CHANGES OBSERVED IN PATIENTS IN THE CONTROL GROUP, ALL THESE IMPROVEMENTS PROVED TO BE SIGNIFICANT. CONCLUSION: ADMINISTRATION OF INTEGRATED YOGA THERAPY TO INDIVIDUALS WITH DIABETES LEADS TO A SIGNIFICANT IMPROVEMENT IN GLYCEMIC CONTROL, INSULIN RESISTANCE, AND KEY BIOCHEMICAL PARAMETERS. 2022 16 2475 28 YOGA AS AN ADJUNCT FOR MANAGEMENT OF OPIOID DEPENDENCE SYNDROME: A NINE-MONTH FOLLOW-UP CASE REPORT. OPIOID DEPENDENCE SYNDROME (ODS) IS A CHRONIC RELAPSING REMITTING CONDITION ASSOCIATED WITH SIGNIFICANT IMPAIRMENT AND MORTALITY RISK. OPIOID SUBSTITUTION THERAPY IS USED WORLDWIDE, BUT LONG-TERM RETENTION RATES ARE LOW AND THERE IS RISK OF MISUSE AND DIVERSION. YOGA PRACTICE CAN IMPROVE QUALITY OF LIFE, REDUCE CHRONIC PAIN, AND ENHANCE ENDOGENOUS OPIOIDS (BETA-ENDORPHINS). WE DESCRIBE A CASE OF ODS WHERE YOGA WAS ADDED TO THE CONVENTIONAL MANAGEMENT AND WHO WAS FOLLOWED UP FOR 9 MONTHS. ASSESSMENTS WERE DONE FOR CLINICAL SYMPTOMS, URINE DRUG SCREENING, PLASMA BETA-ENDORPHINS, AND BUPRENORPHINE DOSAGE. WE OBSERVED AN IMPROVEMENT IN HIS CLINICAL SYMPTOMS AND REDUCTION IN THE REQUIREMENTS FOR BUPRENORPHINE. A SLIGHT INCREASE IN BASAL PLASMA BETA-ENDORPHIN LEVELS WAS ALSO OBSERVED AT THE 9-MONTH FOLLOW-UP (FROM 2.02 PMOL/L AT BASELINE TO 6.51 PMOL/L). 2021 17 1453 28 INFLUENCE OF PRANAYAMAS AND YOGA-ASANAS ON SERUM INSULIN, BLOOD GLUCOSE AND LIPID PROFILE IN TYPE 2 DIABETES. A DISTINGUISHABLE FEATURE OF TYPE 2 DIABETES BESIDES HYPERGLYCEMIA AND DERANGED LIPID PROFILE IS AN IMPAIRED INSULIN SECRETION, PERIPHERAL INSULIN RESISTANCE AND OBESITY WHICH HAS BECOME A MAJOR HEALTH CONCERN WORLDWIDE. INDIA WITH AN ESTIMATED 31MILLION DIABETICS IN 2000 AND 79MLLIONS BY THE YR 2030 HAS THE HIGHEST NUMBER OF TYPE 2 DIABETICS IN THE WORLD. IN THIS STUDY, WE AIMED TO SEE IF YOGA-ASANAS AND PRANAYAMAS HAVE ANY INFLUENCE IN MODIFYING CERTAIN BIOCHEMICAL PARAMETERS. SIXTY PATIENTS OF UNCOMPLICATED TYPE 2 DIABETES (AGE 35-60 YRS OF 1-10 YRS DURATION) WERE DIVIDED INTO TWO GROUPS: GROUP 1 (N=30): PERFORMED YOGA ALONG WITH THE CONVENTIONAL HYPOGLYCEMIC MEDICINES AND GROUP 2 (N=30): PATIENTS WHO ONLY RECEIVED CONVENTIONAL MEDICINES. DURATION OF THE STUDY WAS 45 DAYS. BASAL RECORDINGS OF BLOOD GLUCOSE (FASTING AND POST-PRANDIAL), LIPID PROFILE AND SERUM INSULIN WERE TAKEN AT THE TIME OF RECRUITMENT AND THE SECOND READING AFTER FORTY FIVE DAYS. RESULTS SHOWED A SIGNIFICANT IMPROVEMENT IN ALL THE BIOCHEMICAL PARAMETERS IN GROUP 1 WHILE GROUP 2 SHOWED SIGNIFICANT IMPROVEMENT IN ONLY FEW PARAMETERS, THUS SUGGESTING A BENEFICIAL EFFECT OF YOGA REGIMEN ON THESE PARAMETERS IN DIABETIC PATIENTS. 2008 18 1928 31 ROLE OF YOGA IN DIABETES. THE SCIENCE OF YOGA IS AN ANCIENT ONE. IT IS A RICH HERITAGE OF OUR CULTURE. SEVERAL OLDER BOOKS MAKE A MENTION OF THE USEFULNESS OF YOGA IN THE TREATMENT OF CERTAIN DISEASES AND PRESERVATION OF HEALTH IN NORMAL INDIVIDUALS. THE EFFECT OF YOGIC PRACTICES ON THE MANAGEMENT OF DIABETES HAS NOT BEEN INVESTIGATED WELL. WE CARRIED OUT WELL DESIGNED STUDIES IN NORMAL INDIVIDUALS AND THOSE WITH DIABETES TO ASSESS THE ROLE OF YOGIC PRACTICES ON GLYCAEMIC CONTROL, INSULIN KINETICS, BODY COMPOSITION EXERCISE TOLERANCE AND VARIOUS CO-MORBIDITIES LIKE HYPERTENSION AND DYSLIPIDEMIA. THESE STUDIES WERE BOTH SHORT TERM AND LONG-TERM. THESE STUDIES HAVE CONFIRMED THE USEFUL ROLE OF YOGA IN THE CONTROL OF DIABETES MELLITUS. FASTING AND POSTPRANDIAL BLOOD GLUCOSE LEVELS CAME DOWN SIGNIFICANTLY. GOOD GLYCAEMIC STATUS CAN BE MAINTAINED FOR LONG PERIODS OF TIME. THERE WAS A LOWERING OF DRUG REQUIREMENT AND THE INCIDENCE OF ACUTE COMPLICATIONS LIKE INFECTION AND KETOSIS WAS SIGNIFICANTLY REDUCED. THERE WERE SIGNIFICANT CHANGES IN THE INSULIN KINETICS AND THOSE OF COUNTER-REGULATORY HORMONES LIKE CORTISOL. THERE WAS A DECREASE IN FREE FATTY ACIDS. THERE WAS AN INCREASE IN LEAN BODY MASS AND DECREASE IN BODY FAT PERCENTAGE. THE NUMBER OF INSULIN RECEPTORS WAS ALSO INCREASED. THERE WAS AN IMPROVEMENT IN INSULIN SENSITIVITY AND DECLINE IN INSULIN RESISTANCE. ALL THESE SUGGEST THAT YOGIC PRACTICES HAVE A ROLE EVEN IN THE PREVENTION OF DIABETES. THERE IS A BENEFICIAL EFFECT ON THE CO-MORBID CONDITIONS LIKE HYPERTENSION AND DYSLIPIDEMIA. 2007 19 94 27 A NARRATIVE REVIEW ON ROLE OF YOGA AS AN ADJUVANT IN THE MANAGEMENT OF RISK FACTOR, DISEASE PROGRESSION AND THE COMPLICATIONS OF TYPE 2 DIABETES MELLITUS. TYPE 2 DIABETES MELLITUS (T2DM) IS ONE OF THE MAJOR HEALTH PROBLEMS IN THE WORLD AS WELL AS IN INDIA THAT GREATLY AFFECTS THE HEALTH CARE SECTOR AND ECONOMY. USE OF DRUGS HAS ITS OWN DRAWBACKS AND IN RECENT DAYS THE USE OF NON-MEDICAL MEASURES WERE REPORTED NOT ONLY TO MANAGE T2DM, BUT ALSO TO PREVENT ITS COMPLICATIONS. THROUGH THERE ARE VARIOUS REVIEW ARTICLES THAT ARE DEALING WITH THE EFFECT OF YOGA ON RISK PROFILES, MANAGEMENT ALONG WITH THE MECHANISMS OF ACTION OF YOGA IN T2DM SEPARATELY, THERE IS A LACK OF COMPREHENSIVE REVIEW ON THE EFFECT OF YOGA IN COMBINATION WITH ALL THE ABOVE MENTIONED INCLUDING THE EFFECT OF YOGA IN THE MANAGEMENT OF T2DM COMPLICATIONS. HENCE, WE PERFORMED A NARRATIVE REVIEW IN MEDLINE/PUBMED USING KEYWORD "YOGA AND DIABETES". ALL THE RELEVANT ARTICLES PUBLISHED TILL 08TH NOVEMBER 2016 WERE INCLUDED. BASED ON THE AVAILABLE LITERATURE, IT COULD BE CONCLUDED THAT YOGA PLAYS A VITAL ROLE AS AN ADJUVANT IN THE MANAGEMENT OF RISK FACTORS, DISEASE PROGRESSION AND THE COMPLICATIONS OF THE T2DM. FURTHER STUDIES ARE WARRANTED USING STANDARD RESEARCH DESIGNS AND VARIABLES TO FIND OUT THE VARIOUS MECHANISMS OF EFFECTS OF YOGA IN DETAIL. 2017 20 496 30 COMBINATION OF AYURVEDA AND YOGA THERAPY REDUCES PAIN INTENSITY AND IMPROVES QUALITY OF LIFE IN PATIENTS WITH MIGRAINE HEADACHE. OBJECTIVES: TO UNDERSTAND THE EFFICACY OF AYURVEDA AND YOGA IN THE MANAGEMENT OF MIGRAINE HEADACHE. METHODS: 30 SUBJECTS RECRUITED TO AYURVEDA AND YOGA (AY) GROUP UNDERWENT TRADITIONAL PANCHAKARMA (BIO-PURIFICATORY PROCESS) USING THERAPEUTIC PURGATION FOLLOWED BY YOGA THERAPY, WHILE 30 SUBJECTS OF CONTROL (CT) GROUP CONTINUED ON SYMPTOMATIC TREATMENT (NSAID'S) FOR 90 DAYS. BODY CONSTITUTION QUESTIONNAIRE WAS ADMINISTERED TO BOTH GROUPS. THE OUTCOME MEASURES INCLUDED SYMPTOM CHECK LIST, COMPREHENSIVE HEADACHE RELATED QUALITY OF LIFE QUESTIONNAIRE AND VISUAL ANALOGUE SCALE. RESULTS: FORTY-SIX (76.6%) OUT OF 60 SUBJECTS BELONGING TO BOTH GROUPS HAD PITTA BASED BODY CONSTITUTION. FOLLOWING 90 DAYS OF INTERVENTION THE AY GROUP SHOWED SIGNIFICANT REDUCTION IN MIGRAINE SYMPTOMS INCLUDING PAIN INTENSITY (P<.001) AND IMPROVEMENT IN HEADACHE RELATED QUALITY OF LIFE (P<.001). THE CT GROUP SHOWED NO SIGNIFICANT CHANGE (P>.05). CONCLUSION: TRADITIONAL AYURVEDA ALONG WITH YOGA THERAPY REDUCES SYMPTOMS, INTENSITY OF PAIN AND IMPROVES QUALITY OF LIFE IN MIGRAINE PATIENTS. 2018